Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD (RADIANT)
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Sponsor: StemCells, Inc.
Terminated
Based on a business decision unrelated to any safety concerns.
Other terminated trials from StemCells, Inc.
- Spinal Cord Injury · May 2016
- Age-Related Macular Degeneration · May 2016
- Cervical Spinal Cord Injury · Phase PHASE2 · May 2016
More terminations from StemCells, Inc.
Other Age-Related Macular Degeneration trials with similar outcome
Listed as NCT02467634, this PHASE2 trial focuses on Age-Related Macular Degeneration and remains terminated or withdrawn. Sponsored by StemCells, Inc., it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- StemCells, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .